The overall lifetime cancer risk in LS depends on the affected MMR gene and is estimated to vary between 50% and 80% for the high penetrance genes, MLH1 and MSH2 [26,27,28,29,30,31,32]. This evidence concerns the gene MLH1 and cancer.